Latest Market Strategy News

Bapcor Limited has revised its first-half FY26 guidance to a statutory net loss, citing weaker trade segment performance and one-off costs, while maintaining a cautiously optimistic full-year outlook supported by cost savings and leadership changes.

Yari Minerals has completed four drillholes at its Rolleston South Coal Project, confirming thick, continuous coal seams and progressing towards upgrading part of its 190.1 Mt Inferred Resource to Indicated status.

Assetora Limited has raised $500,000 through a private placement, issuing 3.57 million shares with options attached, signaling strong investor confidence in its alternative assets strategy.

Linius Technologies, soon to be Ion Video Limited, appoints Sophie Karzis as company secretary and Canaccord Genuity as corporate advisor, signaling a strategic push in governance and capital markets engagement.

Ovanti Limited’s U.S. BNPL arm, Flote, has signed a Letter of Intent with Nasdaq-listed Miluna Acquisition Corp for a $300 million valuation, aiming for a Nasdaq listing while preserving Ovanti’s majority ownership.

Prophecy International Holdings reports a modest revenue dip and net loss in FY25, cancels its Complexica merger, and pivots to AI-driven product innovation and cost control.

Recce Pharmaceuticals has secured a key patent in Hong Kong for its synthetic anti-infectives, reinforcing its intellectual property footprint in Asia and supporting its clinical and commercial ambitions in the region.

Locksley Resources has kicked off its maiden drilling at the El Campo Rare Earths Prospect and secured full regulatory approval for an expanded program at the Desert Antimony Mine, setting the stage for continuous exploration updates through mid-2026.

Minbos Resources is advancing its Cabinda Phosphate and Capanda Green Ammonia projects with secured financing and construction underway, targeting first shipments in the first half of 2026. Strategic partnerships and government support underpin its ambitious plans to boost Angola’s agricultural and export sectors.

Proteomics International secures a key Medicare reimbursement rate for its PromarkerD test, a predictive diagnostic for diabetic kidney disease, marking a critical step in its US commercial rollout.

Lumos Diagnostics has achieved a major milestone by securing 100% Medicare reimbursement recognition for its FebriDx test across all seven US Medicare Administrative Contractors, paving the way for broader adoption in the American healthcare system.

Reece Limited reported a modest revenue decline and earnings pressure in FY25 amid challenging markets but reinforced its long-term growth strategy with a significant share buyback and board renewal. Early FY26 trading shows sales growth driven by network expansion despite ongoing cost pressures.